DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Gerstein HC, Colhoun HM, Dagenais GR. et al
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet 2019;
394: 121-130 . doi:10.1016/s0140-6736(19)31149-3
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.